Celtechnology

Celtechnology Co., Ltd. is a Japanese company specializing in regenerative medicine, focusing on the cryopreservation of dental pulp stem cells. Founded on October 15, 2015, with Namiko Shinohara as the Representative Director, the company operates under the registered trademark "Dental Pulp Cell Bank".

The firm's core business is its Dental Pulp Cell Bank, which stores stem cells extracted from the dental pulp of baby teeth and wisdom teeth for future use in regenerative medicine. This service offers individuals a way to preserve their own potent stem cells for potential therapeutic applications. The process involves coordinating with certified dental facilities for tooth extraction, after which the cells are cultured and stored. While the best results come from professionally extracted teeth, the company also accepts naturally fallen baby teeth, albeit with a noted higher risk of culture failure due to potential infection.

Celtechnology also engages in the business of handling culture supernatant fluid. The company has gained media attention in Japan for its work in making regenerative medicine more accessible, particularly its initiatives around using donated teeth for research and treatment, such as bone regeneration for the elderly.

Keywords: regenerative medicine, dental pulp stem cells, cryopreservation, cell banking, stem cell storage, culture supernatant fluid, Japanese biotechnology, Namiko Shinohara, wisdom teeth stem cells, baby teeth stem cells, cell therapy, tissue engineering, life sciences, healthcare innovation, medical biotechnology